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Abstract:  
Aim: The study aimed to examine changes in some health indicators in people with type 2 diabetes mellitus, namely: 
reported self-care activity, health related quality of life, and patient opinion of the services provided by three community 
pharmacies in Sharjah, UAE. Method: A group of patients was followed over 24 months. Patients under investigation 
received reminders packages during the first three months of the study. No reminders were sent after 3 months after the 
study was underway. Repeated measures ANOVA were used to test differences between means over different periods. 
Results: All patients included in this study were found to have poor diet and exercise behavior at baseline. Three months 
into the study, more than 27% of the patients had acceptable diet, exercise, foot care and self-testing behavior. However, 
evaluation at six months and 24-months show that mean scores had almost returned to baseline levels. There were 
significant differences between the mean values of initial (baseline data) and final (at the end of the study) scores for general 
health (5.86, p=0.001), vitality (5.25, p<0.001), and role physical scales (3.81, p=0.02). There was a significant (p < 0.001) 
25% increase in the patients' perception of the ability of the pharmacist to assist in decreasing blood glucose level. 
Conclusion: Ongoing reminder packages are needed for continued progress in self-care activities and for achieving lasting 
changes in the behavior. Implementation of such a strategy through community pharmacies could help to improve patients’ 
views of the quality of services received from these pharmacies and patient’s quality of life, which should improve patient’s 
drug therapy and reduce complications of diabetes. 
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Introduction 
Economic growth and development in the oil-exporting 
countries over the past three decades has been dramatic. 
This socio-economic development has brought benefits to 
many people in the region, such as improved access to 
health care, education, and safe drinking water. However, 
economic development has set the scene for the 
transformation of lifestyle, eating habits, and traditional 
societal and family structures. These changes are not all 
for the better. Chronic diseases, such as diabetes mellitus, 
which are linked both directly and indirectly to behavioral, 
nutritional and environmental factors, have emerged as 
the leading cause of morbidity and mortality in different 
countries [1,2].  
 
Data on the prevalence of diabetes mellitus in the 
United Arab Emirate (UAE) are limited, but it appears that 
it is an important problem. It has been reported that 
deaths attributable to diabetes accounted for 2-3% of all 
deaths in the UAE in the last ten years, and that diabetes 
is set to affect half the UAE population in the next 25 
years unless people change their lifestyle and become 
more active [3,4].  
 
Diabetes is largely self-managed, and successful models 
of care must focus on strategies that promote and 
maintain improved self-care behavior. Drugs are only part 
of the plan for managing type 2 diabetes. Other 
interventions, such as patient education, modification of 
diet and promotion of exercise remain cornerstones for 
management of this chronic condition [5]. Accordingly, 
effective diabetes self-management training has been 
developed and the challenge now is to package, monitor, 
and consistently deliver these interventions effectively in a 
way that is practical in terms of the time and resources 
required for reaching the target population [6]. Worldwide 
use of reminders by telephone or mail, individualised 
reminder charts, diaries, and engaging family members 
and carers to provide reminders were found to be 
effective in monitoring patients and promoting behavioral 
changes [7-10]. The Summary of Diabetes Self-Care 
Activities (SDSCA) measure was developed as a brief self-
report instrument for measuring levels of self-
management across different components of the diabetes 
regimen [11,12]. Also, evaluation of the quality of life, 
using the short-form 36-item (SF-36), has been 
recognised increasingly as a useful criterion for evaluating 
medical outcome, for understanding the physical, 
emotional, and social impacts of disease, and for 
measuring the perception of the services provided by 
health care professionals to target chronic diseases [13].   
 
The general health scale is an indication of patients’ 
perception of their health status, in general and in 
comparison with others. The vitality scale provides insight 
into how energetic patients feel. The role physical scale is 
a reflection of the impact of physical health on work or 
other daily activities. These scales are expected to show 
improvement of patients undergoing a programme that 
emphasises exercise and positive lifestyle changes. 
 
In the UAE, the health care system is well developed 
and the predominantly governmental facilities offer their 
services to all citizens. However, outside the secondary 
care sector the majority of patients obtain their medication 
from the growing number of private community 
pharmacies. Although pharmacy practice in community 
pharmacies in the Gulf area,  s u c h  a s  i n  t h e  U A E ,  h a s  
shown some improvement during the last 15 years, it has 
not yet fully gained the trust of the public or indeed of 
health professionals. This seems to be due to several 
reasons, including the public and the health professionals’ 
        
www.ljm.org.ly      
 
Page 31DOI: 10.4176/080918    Original Article     
  
  
 
perception of pharmacists as lacking in professionalism, 
commercial pressure on community pharmacies, and a 
lack of enforcement of the regulations governing 
pharmacy practice within both the community and in 
hospitals [14]. Evolution of new roles for the community 
pharmacist is highly topical [15], and people with type 2 
diabetes present an ideal opportunity to develop a service 
needed by society. The objective of this study was to 
examine changes in some health indicators in patients 
with type 2 diabetes mellitus who receive reminder 
packages through community pharmacists, namely, 
reported self-care activity, health related quality of life, 
and patients’ opinion of the services provided by 
community pharmacists.  
 
Methods 
Study Sample 
Fifteen community pharmacies, chosen to be a 
representative cross-section across the Sharjah Health 
Authority, were contacted by telephone. The pharmacy 
names, addresses, and telephone contact numbers were 
collected randomly using the DOHMS, Dubai Health 
Directory for 2008 available at 
http://www.dohmsdirectory.com.  Only three pharmacies 
agreed to participate in the study and to provide the 
package to patients visiting them. All of them stated that 
an Arabic version should be produced for those who 
cannot read English. Preparation of the package in Arabic 
involved more than simple translation. Sometimes a term 
in Arabic could not be found for a medical term in English. 
Moreover, direct translation of an English phrase might be 
meaningless in Arabic or even lead to misunderstanding 
unless it was elaborated or qualified. For this reason, a 
booklet containing a summary of these packages was 
produced in Arabic and incorporated into the final versions 
before use. However, to avoid the affect of such factors 
on the study outcomes, the English version of the package 
was used with all interviewed patients throughout the 
study period.  Patients were also encouraged to consult 
the Arabic summary if they needed any further 
clarifications.  Seventy-five patients with type 2 diabetes 
mellitus were recruited, as initially agreed with the 
pharmacists. The patients were identified during 
prescription dispensing, and those who were on oral anti-
diabetic agents were invited to take part in the study. 
Each patient was interviewed by the researcher based in 
UAE for 15–30 minutes to identify patients who met the 
inclusion criteria, and to collect data on their 
understanding of diabetes and associated topics. To 
minimise any bias, the interview as structured and the 
patients were asked the same questions, in the same 
sequence, and in the same tone of voice. The nature of 
the study was explained fully to each patient, and once 
they fully understood that they were required to use the 
same pharmacy during the study, they were asked to sign 
a consent form. They were assured that their responses 
would be treated confidentially and that their participation 
in the study would not affect their medical treatment. 
Patients were excluded from the trial for the following 
reasons: age over 85 years, abnormal renal or hepatic 
function, known pregnancy, overt cardiovascular disease, 
any chronic disease, psychological or physical disability, if 
they refused to take part in the study or to sign the 
consent form, or inability to speak Arabic or English. 
Patients were asked if they were regular patients at any 
cardiovascular, renal, or hepatic clinics and their doctors 
were identified. The doctors were approached, either 
directly or by telephone, in order to discuss the study 
details and to obtain from them permission to enrol their 
patients in the study. 
 
Stages of the Trial 
Stage 1: For baseline purposes, the patients were asked 
to complete the SDSCA measure with the researcher 
based in UAE (a validated survey for measuring levels of 
diabetes self-care activity), the SF-36 (a validated health-
related quality of life instruments), and patient opinion 
surveys (an unvalidated series of questions prepared by 
the researcher).  The SF-36 (generic) is a multi-item scale 
measuring eight health concepts, which can be 
summarised as follows. (1) Physical functioning is a ten-
question scale that captures abilities to deal with the 
physical requirement of life, such as attending to personal 
needs, walking, and flexibility. (2) Bodily pain is a two-
item scale that evaluates the perceived amount of pain 
experienced during the previous four weeks and the 
extent to which that pain interfered with normal work 
activities. (3) Social functioning (SF) is a two-item scale 
that evaluates the extent and amount of time, if any, that 
physical health or emotional problems interfered with 
family, friends, and other social interactions during the 
previous four weeks. (4) Role-emotional (RE) is a three-
item scale that evaluates the extent, if any, to which 
emotional factors interfere with work or other activities. 
(5) Mental health is a five-item scale that evaluates 
feelings, principally of anxiety and depression. 
  
Stage 2: Clear and concise standardised information on 
different regimens of diabetes self-care was given as a 
reminder to every patient every week during the first 
three months. The reminders covered body weight, 
physical activity, dietary habit, self-testing, foot care, 
smoking habits, blood pressure and dyslipidaemia.  
 
Stage 3: Three months into the trial the patient was 
asked to complete the SDSCA, SF-36, and patient opinion 
surveys. No more reminders were sent for a further three 
and 18-months of the study period. The SF-36 survey was 
used and scored according to the instructions in the SF-36 
manual [16]. An unvalidated series of 10 questions 
prepared by the researcher based in UAE was used to 
gauge patient opinion of the services provided by 
community pharmacists. (A copy of the entire final version 
of SDSCA form used in this study is available from the 
authors).  
 
Stage 4: Six months into the study, the SDSCA was sent 
together with a covering letter to each patient. The 
covering letter included a 'thank you' to the patient for the 
decision to participate in the study, and a reminder 
requesting that the last form be completed as objectively 
as possible so as to reflect actual practices. At 24 months 
the SDSCA was repeated with an aim to track the patients 
activities and level of adherence. This was done in an 
effort to avoid any influence of the reminder packages 
given during the first 3 months of study period. 
 
Statistical Analysis 
The responses to the SDSCA measure were scored 
according to the instructions in the handbook of diabetes 
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self-care activities questionnaire [11,12]. Scores are 
calculated for each of the five regimen areas assessed by 
the SDSCA: general diet, specific diet, exercise, foot care, 
and blood sugar testing. Mean number of days (±SD) for 
the items was calculated, reversing the item (On how 
many of the last 7 days have you eaten red meat, full fat 
dairy product, cake, ice cream, or "take away" food?) in 
specific diet (0=7, 1=6, 2=5, 3=4, 4=3, 5=2, 6=1, 7=0).  
Statistical analysis was performed using the Statistical 
Package for Social Sciences (SPSS) for Windows Version 
10.1 and S-PLUS Professional Version 6.1.  Repeated 
measures analysis of variance (ANOVA) was used to 
compare patient self-care reported between baseline, 
three-month, six-month, and 24-month reported scores, 
between three-, six-, and 24-month, and between six- and 
24-month (Table 1). Before analysis, the Ryan-Joiner test 
for normality was applied to test the appropriateness of 
the data (i.e. to test the differences between 
measurement intervals). All 15 such variables passed this 
test above the cut-off value of 0.10 (null hypothesis). In 
effect, with single group repeated measures ANOVA, the 
data are subjected to a series of one-sample tests with 
appropriate weighting to take into account the repeated 
nature of the statistical testing. 
 
Demographic characteristics were summarised using 
means and standard deviations or frequencies and 
percentages. Means and standard deviations were 
calculated for SF-36 and for patients’ answers on the 
series of questions gauging patient opinion of the services 
provided by community pharmacists. Student’s t-tests 
were used to estimate the level of significance of the 
mean difference between the initial and final scores of 
both surveys. Statistical significance for all analyses was 
defined as p≤0.05. 
 
Results 
Of the 75 patients with type 2 diabetes evaluated here, 
16 were excluded: four due to their belief in the drug that 
they use and that there was therefore no need for any 
further lifestyle changes. Six patients dropped out due to 
lack of interest, insufficient time, or an unwillingness to 
comply with the process. Three were excluded because 
they later claimed to have linguistic difficulties, not being 
able to speak either Arabic or English. One was excluded 
because of physical disability, and two because they felt 
that such involvement was not an appropriate role for 
pharmacists. The remaining 59 patients completed the 
study and responded to all items of the SDSCA measure. 
Of these, 32 (54%) were female and 25 (42%) were UAE 
national. The average age was 51±11.3 years (range 28-
75).   
 
Among these 59 patients, the average duration of 
known diabetes was 9±3.6 years (range 2-20).  More than 
sixty percent (61%) of them reported use of at least one 
medication for treatment of hypertension. More than half 
(52%) of male diabetic patients reported that they were 
heavy smokers, and almost 90% of both males and 
females were classified as physically inactive.  
 
The average Body Mass Index (BMI) (kg/m2) at the 
beginning of the study (25.3±3.2) was significantly higher 
(29.2±3.8) than at 24 months (P<0.001). At the beginning 
of the study more than one quarter (26%) of male 
patients and half (50%) of female patients were classified 
as obese (BMI >30 kg/m2). At 24 months, almost 47% of 
the patients had a body weight between 80 to 100 kg and 
10% had body weight of more than 100 kg. However, the 
percentage of male and female patients classified as 
obese at 24-months was similar to the findings at the 
beginning of the study. Seventeen per cent of patients 
studied reported treatment of diabetic foot problems 
during the study. However, female patients (60%) were 
more than male patients (24%) in taking care of their foot 
and wearing comfortable shoes. Data on A1C and lipid 
profile were not collected because community pharmacies 
in the UAE do not have access to patients’ laboratory data.  
 
An important proportion of the pooled sample had no 
idea about the disease definition (25%), disease risk 
factors (23%), disease complications (33%), and disease 
symptoms (20%), apart from high urination frequency, 
w h i c h  w a s  i d e n t i f i e d  b y  m o r e  t h a n  9 5 %  o f  t h e m .    
Furthermore, more than 85% of respondents considered 
traditional remedies and herbal medicine to be the best 
option for the management of diabetes. Most of them 
(80%) use at least one oral anti-diabetic agent and only 
25% considered lifestyle modification important in 
diabetes management. 
 
The mean and 95% confidence intervals for each 
subscale of SDSCA measure provide information for 
comparative purposes (higher numbers indicate better 
self-care on all scales). These means show considerable 
consistency across different measure subscales at 
baseline, with patients typically reporting low levels of 
self-care behavior regarding diet, exercise, foot care, and 
self-testing. At 3 months, the mean number of days per 
week that patients exhibited good diet behavior was 
2.92±1.01 for both general and specific diet. The mean 
number of days per week on which patients undertook 
daily exercise (minimum 30 min) was 2.88±1.04. On the 
other hand, the mean number of days per week that 
patients carried out foot care and self-testing behavior 
were 2.93±1.10, and 2.61±1.05, respectively. All patients 
were considered to have poor diet behavior (i.e., on less 
than five days per week and poor exercise behavior (on 
less than three days per week) at baseline according to 
their responses on the scale used by the SDSCA. This 
percentage decreased to 71.2 for diet and exercise at the 
3-month observations. At 3 months, more than 27% of 
patients were considered to have acceptable diet, 
exercise, foot care and self-testing behavior (between four 
and five days per week). However, results at 6 months 
and 24 months show that mean scores had almost 
returned to baseline levels. At 24 months, the mean 
number of days per week that patients exhibited good diet 
behavior was 1.66±0.90 (1.24±0.88, baseline) for general 
and 1.80±0.78 (1.78±0.97, baseline) for specific diet. The 
mean number of days per week on which patients 
undertook daily exercise (minimum 30 min) was 
1.54±0.79 (1.17±0.75, baseline). On the other hand, the 
mean number of days per week that patients carried out 
foot care and self-testing behavior were 1.46±1.18 
(baseline 1.12±0.70) and 1.71±0.71 (baseline 
1.19±0.51), respectively. The mean difference (baseline to 
24-months) for general diet, specific diet, exercise, foot 
care, and self-testing were 0.42, p=0.064; -0.02, 
p=0.998; -0.37, p=0.057; -0.34, p=0.312; and –0.53, 
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p<0.001, respectively.  Repeated measures ANOVA were 
used to test differences between means from baseline to 3 
months, baseline to 6 months, baseline to 24 months, 3 
month to 6 months, 3 months to 24 months; and 6 
months to 24 months (Table 1).   
 
All people under investigation completed the SF-36 
survey at the baseline (initial scores) and 3-months (final 
scores) of the study. There were significant mean 
differences between the initial and final scores for general 
health (5.86, p=0.001), vitality (5.25, p<0.001), and role 
physical scales (3.81, p=0.02) (Table 2). No significant 
changes were detected in the remaining scales. 
 
Table 1  Repeated measures analysis of variance (ANOVA: 
pairwise multiple comparison) was used to test differences 
between means of SDSCA measures reported between baseline, 
three-month, six-month, and 24-month reported scores); 
between three, six months, and 24-month; and between six and 
24-months. 
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General diet 
Baseline - 3 months 
Baseline - 6months 
Baseline - 24 months 
3–6 months 
3–24 months 
6 –24 months 
 
-1.68* 
-0.63* 
-0.42 
1.05* 
1.25* 
0.20 
 
<0.001 
0.001 
0.064 
<0.001 
<0.001 
0.75 
 
-2.14 to -1.21 
-1.05 to -0.20 
-0.86 to -0.02 
0.59 to 1.51 
0.78 to 1.72 
-0.23 to 0.63 
Specific diet 
Baseline - 3 months 
Baseline - 6months 
Baseline - 24 months 
3–6 months 
3– 24 months 
6 –24 months 
 
-1.14* 
-0.12 
-0.02 
1.02* 
1.12* 
0.10 
 
<0.001 
0.976 
0.998 
<0.001 
<0.001 
0.981 
 
-1.62 to -0.65 
-0.55 to 0.31 
-0.45 to 0.42 
0.57 to 1.46 
0.67 to 1.56 
-0.28 to 0.49 
Exercise 
Baseline - 3 months 
Baseline - 6months 
Baseline - 24 months 
3–6 months 
3– 24 months 
6 –24 months 
 
-1.71* 
-1.08* 
-0.37 
0.63* 
1.34* 
0.71* 
 
<0.001 
<0.001 
0.057 
0.009 
<0.001 
<0.001 
 
-2.16 to -1.27 
-1.54 to -0.63 
-0.75 to -0.03 
0.11 to 1.14 
0.88 to 1.79 
0.25 to 1.17 
Foot care 
Baseline - 3 months 
Baseline - 6months 
Baseline - 24 months 
3–6 months 
3– 24 months 
6 –24 months 
 
-1.81* 
-1.12* 
-0.34 
0.69* 
1.47* 
0.78* 
 
<0.001 
<0.001 
0.312 
0.014 
<0.001 
0.006 
 
-2.27 to -1.36 
-1.64 to -0.60 
-0.82 to 0.14 
0.19 to 1.29 
0.91 to 2.04 
0.16 to 1.40 
Self-testing 
Baseline - 3 months 
Baseline - 6months 
Baseline - 24 months 
3–6 months 
3– 24 months 
6 –24 months 
 
-1.42* 
-0.44 
-0.53* 
0.98* 
0.90* 
-0.08 
 
<0.001 
0.075 
<0.001 
<0.001 
<0.001 
0.998 
 
-1.83 to -1.01 
-0.91 to -0.02 
-0.84 to -0.21 
0.42 to 1.55 
0.45 to 1.35 
-0.59 to 0.42 
* = P≤0.05 
 
Table 3 shows the respondents’ opinions on the ten 
questions used to gauge patient opinion of the services 
provided by community pharmacists. Although this was an 
invalidated instrument, it provided some insight into 
changes in patients’ perceptions of the services provided 
by community pharmacists at baseline and at the 3-
months of the study. The responses at 3 months were 
generally better than those at baseline. When patients 
were asked about the idea of being able to have a 
diabetes test done in a pharmacy (question 1), about 42% 
responded “agree” or “strongly agree” at baseline. 
Table 2  SF-36 survey results (n=59) 
Mean ± SD 
Scale   Initial 
scores
Final scores 
     
Level of   
significance 
   
(Student’s 
t-test)   
Physical 
functioning  
62.71±25.21  
64.79±17.84 0.098 
Role-physical  53.39±43.17   57.20±32.14 
 
0.023 
Bodily pain  60.78±23.45   62.66±20.22 
 
0.103 
General 
health  
52.27±26.76   58.14±20.19 
 
0.001 
Vitality  43.38±10.14   48.64±08.14 
 
< 0.001 
Social 
functioning  
46.82±14.97   48.31±12.02 
 
0.089 
Role-
emotional   
58.19±46.56  
61.36±34.13 0.096 
Mental health  51.45±18.15  
53.56±17.71 0.094 
The SF-36 survey was scored according to the instructions in 
the SF-36 manual. All scores are transformed to a scale of 0-100 
points: higher scores indicate a better state of health. Student’s 
test was used to calculate the level of significance. 
 
This figure rose to more than 60% at 3-months. At 
baseline, patients either agreed or strongly agreed by only 
32% and by more than 92% with the statement in 
question 2 (My pharmacist can help me decrease my 
blood glucose level) and question 3 (My doctor can help 
me decrease my blood glucose level) respectively. At the 
3-month stage, the perception of the ability of the 
pharmacist to assist in decreasing blood glucose level had 
increased to more than 56%. The change in the 
evaluation of pharmacists’ abilities was significant (p < 
0.001). Significant changes were also seen in the 
responses of patients to question 6 (How often do you 
forget to take your medication?), question 7 (How often 
do you forget to take your medication when you are away 
from home overnight?), question 8 (Do you take your 
medicine exactly as your doctor instructed?), and question 
9 (How often do you stop taking your medication?), which 
covered the topic of patient behaviors and compliance. 
 
At baseline, only 12% of the participants either agreed 
or strongly agreed with the statement "My diabetic 
medication is no benefit" (Question 4). Therefore, there 
seems to be little doubt that patients in general have faith 
in their drug therapy regimes. This view was further 
reinforced by the fact that only 7% of respondents either 
strongly agreed or agreed with the statement "I feel my 
medication is not working and that it is pointless to 
continue with it in the long term" (Question 5). However, 
in responding to question 10, "How often do you take 
more medication than your doctor prescribed?" 81% 
reported that they either never or very rarely took more 
medication than prescribed. At the 3-month stage, the 
changes in respondents' opinion on questions 4, 5, and 10 
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were non significant. Table 3 shows respondents’ opinion 
(Mean±SD) on the ten questions used for this particular 
study.  
 
Table 3  Respondents’ responses on the five statements and 
five questions used to gauge their opinion of the services 
provided by community pharmacists. 
[Mean±SD] 
Statements/Questions  Baseline 
scores 
3-month 
scores 
Level of 
significance 
(t-test) 
1 
I like the idea of being 
able to have a diabetes 
test done in a pharmacy. 
[3.19±1.42] [3.58±1.30] 0.112 
2 
My pharmacist can help 
me decrease my blood 
glucose level. 
[2.80±1.11] [3.54±1.21] <0.001 
3 
My doctor can help me 
decrease my blood 
glucose level. 
[4.25±0.84] [4.34±0.80] 0.557 
4 
My diabetic medication is 
of no benefit. 
[3.83±1.05] [4.19±1.01] 0.103 
5 
I feel my medication is 
not working and that it is 
pointless to continue with 
it in the long term. 
[4.07±0.87] [4.32±0.86] 0.121 
6 
How often do you forget 
to take your medication? 
[3.85±0.93] [4.32±0.63] 0.001 
7 
How often do you forget 
to take your medication 
when you are away from 
home overnight? 
[3.68±1.17] [4.56±0.60] <0.001 
8 
Do you take your 
medicine exactly as your 
doctor instructed? 
[4.27±1.11] [4.85±0.36] <0.001 
9 
How often do you stop 
taking your medication? 
[4.37±1.05] [4.86±0.35] 0.001 
10 
How often do you take 
more medication than 
your doctor prescribed? 
[4.46±0.79] [4.66±0.60] 0.135 
For statements 1 to 5, the respondents were asked to rate their 
response using the options, strongly agree, agree, somewhat agree, 
disagree, and strongly disagree. For questions 6 to 10, the respondents 
were asked to rate their response using the options, most of the time, 
often, sometimes, very rarely, and never. Scores (1 to 5) were used and 
reversed in statements/questions 4-7, 9 and 10 because of the negative 
wording of the questions; higher values now indicate positive responses. 
 
Discussion 
This study was set up in community pharmacies to test 
the hypothesis that the provision of reminder packages by 
a community pharmacist would have a demonstrable 
effect on outcomes (reported self-care activity, health 
related quality of life, patient opinion of the services 
provided by community pharmacists) in patients with type 
2 diabetes mellitus.  
 
We found that knowledge about type 2 diabetes was 
inadequate, i.e. that a significant proportion had no idea 
about the disease definition (25%) or disease symptoms 
(20%). In view of this and the obesity epidemic, sedentary 
lifestyle and an ageing population in the region, it is not 
surprising that the prevalence of diabetes and its 
complications doubles with each generation [3,17]. 
Furthermore, a significant proportion of people under 
investigation were unaware of the diabetes-associated risk 
factors (23%), diabetes-associated diseases or diabetes 
complications (33%). This is similar to the findings of 
previous studies, which demonstrated that patients with 
type 2 diabetes had negligible knowledge about their 
disease [18,19]. This suggests that the image of diabetes 
itself overshadows knowledge of its complications, which 
are the major causes of morbidity and mortality.  
 
Self-care is essential for managing diabetes, and 
ensuring that patients undertake such programmes is a 
major challenge to the healthcare team. Adoption of a 
healthy lifestyle will almost certainly produce better 
metabolic control of diabetes, which in turn will aid in the 
avoidance of subsequent acute and long-term 
complications of the disease [20]. All patients in the 
present study had poor diet and exercise behavior at 
baseline, and only 27% had acceptable diet and exercise 
behaviors at 3-months. This indicates that there is much 
scope for improvement in these areas of diabetes 
management. This finding might be attributed to 
underestimation of the importance of lifestyle modification 
once medical therapy is started [21].  
 
The reported poor foot care behavior at baseline (2.93) 
and the finding that more than 50% of people under 
investigation were heavy smokers may explain the reason 
why 17% of patients reported treatment of diabetic foot 
problems during the study. With more than 50% of the 
patients under investigation being heavy smokers, it is 
likely that these smokers were unaware that smoking can 
affect the circulation to their feet.  
 
Promoting change and knowing how to support it is an 
important skill for pharmacists [22]. The provision of 
information, education and physiological support that 
facilitates self-management is a cornerstone of diabetes 
care [4]. Our results show that at the 3-month stage all 
scales demonstrated an improvement in reported self-care 
activity compared with the baseline responses. However, 
at the end of the second three-month period and again at 
the 24-month period, during which no reminders were 
sent, mean scores regressed almost to baseline. There 
was a decline at 6-months in the achievements gained at 
3-months but little change between 6-months and 24-
months, suggesting that an ongoing reminder strategy is 
needed to support continued progress in self-care 
activities and to achieve lasting changes in the behavior of 
those people under investigation.  However, whether such 
reminder-phase improvements (at 3-months) are 
associated with lowered glycaemia, decreased 
hospitalisation, and reduction of associated expenditure 
are not known. These longer-term issues deserve further 
study.  
 
The improvement achieved at 3-months and the 
significant difference in the mean final scores of SF-36 
general health (p = 0.001), vitality (p <0.001) and role 
physical (p = 0.023) scales, in addition to the significant 
changes (p < 0.001) in patients response about 
pharmacists’ abilities presented here demonstrate that 
implementation of such a strategy through community 
pharmacies could help in improving patients’ views of the 
quality of services received from their community 
pharmacy and patients’ quality of life, which will improve 
their drug therapy and reduce diabetes complications. The 
findings presented here are consistent with and support a 
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similar study [23] reporting that clinical improvements 
were greatest between baseline and 3-months, with 
stabilization between 3-months and 6-months, and 
insisting on the necessity for a continuous intervention 
strategy to maintain this improvement.   
 
Obesity and inactivity can increase insulin resistance, 
speeding up the onset of type 2 diabetes in the genetically 
predisposed. We found that 26% of males and 50% of 
females were obese, and almost 90% of them combined 
were physically inactive. This corroborates another study, 
which demonstrated that only 12.7% of men and 8.7% of 
women in the Gulf area practiced any kind of exercise 
[17]. Though our sample was small (n=59), the high 
prevalence of obesity and physical inactivity may illustrate 
the potential ill health of the surveyed population. Only 
25% of the patients in this study considered lifestyle 
modification an important element in diabetes 
management. Moreover, in many African and 
Mediterranean communities, overweight is widely 
perceived as a desirable and a sign of good health and 
financial success [3]. We suggest that part of the remedy 
would be to seek a fundamental change in the way 
walking is popularly perceived so that it is no longer 
considered a strictly the low-income transport option.  
 
In no way do we suggest that a reminder strategy by a 
community pharmacy can replace the relationship 
between the patient and the provider (physician, dietician, 
nurse), which is central to diabetes care, or face to face 
interventions to improve patients adherence and 
compliance. But we do suggest that pharmacists in the 
community have the potential to be an integral part of the 
primary healthcare team in delivering holistic patient care 
[24]. We hope that our study would contribute positively 
to the pharmaceutical system in the UAE by promoting a 
greater understanding among the health authorities of the 
role pharmacists can play in the community and their 
important input in the management of chronic diseases 
such as diabetes.  
One limitation of this study is that it included 
pharmacists from only one state. Hence, the results should 
not be generalized to other areas in the UAE or to other 
regions of the Gulf area. Moreover, the before-and-after 
design used in this study, with patients serving as their 
own controls, was not optimal. Furthermore, the study has 
a number of shortcomings, such as (1) the responses 
were based on patient self-recall, and the relationship 
between reported and actual behavior is unknown, (2) the 
short period during which reminder packages were used, 
and (3) the scales used have not been validated in Arabic. 
Furthermore, considering the difference in health care 
systems between the different countries and the fact that 
an individual’s level of adherence may vary over time and 
between different aspects of treatment, our findings may 
not be applicable or be achievable elsewhere. For future 
research the authors recommend that the SDSCA 
questionnaire be used in a crossover study, whereby 
patients are randomly allocated to 'no reminder followed 
by reminder' or 'reminder followed by no reminder' 
groups, in order to develop intervention programs that 
facilitate long-term changes in behavior. 
 
 
 
Conclusion 
Our study found that repeated reminder packages are 
needed to support continued progress in self-care 
activities and to achieve lasting changes in the behavior of 
those people. Such findings, in addition to the significant 
changes in patients’ response about pharmacists’ abilities, 
demonstrate that implementation of such a strategy 
through community pharmacies could help to improve 
patients’ views of the quality of services received from 
their community pharmacy and also patients’ quality of 
life, which will improve their drug therapy and reduce 
diabetes complications.  
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